Your browser doesn't support javascript.
loading
Augmented Reality Navigation System (SIRIO) for Neuroprotection in Vertebral Tumoral Ablation.
Faiella, Eliodoro; Casati, Rebecca; Pileri, Matteo; Pacella, Giuseppina; Altomare, Carlo; Vergantino, Elva; Bruno, Amalia; Beomonte Zobel, Bruno; Grasso, Rosario Francesco.
Afiliación
  • Faiella E; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Casati R; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Pileri M; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Pacella G; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Altomare C; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Vergantino E; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Bruno A; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Beomonte Zobel B; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
  • Grasso RF; Department of Diagnostic and Interventional Radiology, University Hospital Campus Bio-Medico of Rome, Via Alvaro del Portillo, 200, 00128 Rome, Italy.
Curr Oncol ; 31(9): 5088-5097, 2024 Aug 30.
Article en En | MEDLINE | ID: mdl-39330004
ABSTRACT
(1) This study evaluates the impact of the CT-guided SIRIO augmented reality navigation system on the procedural efficacy and clinical outcomes of neuroprotection in vertebral thermal ablation (RTA) for primary and metastatic bone tumors. (2)

Methods:

A retrospective non-randomized analysis of 28 vertebral RTA procedures was conducted, comparing 12 SIRIO-assisted and 16 non-SIRIO-assisted procedures. The primary outcomes included dose-length product (DLP) and epidural dissection time. The secondary outcomes included technical success, complication rates, and pain scores at procedural time (VAS Time 0) and three months post-procedure (VAS Time 1). The statistical analyses included t-tests, Mann-Whitney U tests, and multiple regression. (3)

Results:

SIRIO-assisted procedures significantly reduced DLP (307.42 mGycm vs. 460.31 mGycm, p = 2.23 × 10-8) and procedural epidural dissection time (13.48 min vs. 32.26 min, p = 2.61 × 10-12) compared to non-SIRIO-assisted procedures. Multiple regression confirmed these reductions were significant (DLP ß = -162.38, p < 0.001; time ß = -18.25, p < 0.001). Pain scores (VAS Time 1) did not differ significantly between groups, and tumor type did not significantly influence outcomes. (4)

Conclusions:

The SIRIO system enhances neuroprotection efficacy and safety, reducing radiation dose and procedural time during spine tumoral ablation while maintaining consistent pain management outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Realidad Aumentada Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Curr Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Realidad Aumentada Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Curr Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia